Clerk of the House of Representatives
Legislative Resource Center
135 Cannon Building
Washington, DC 20515
http://lobbyingdisclosure.house.gov 		Secretary of the Senate
Office of Public Records
232 Hart Building
Washington, DC 20510
http://www.senate.gov/lobby
LOBBYING REPORT

Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

1. Registrant Name Organization/Lobbying Firm Self Employed Individual
American College of Surgeons Professional Association

2. Address

Address1
20 F STREET NW
 Address2
​SUITE 1000
City
WASHINGTON
 State
DC
 Zip Code
20001
 Country
USA

3. Principal place of business (if different than line 2)

City
​
State
​
Zip Code
​
Country
​
4a. Contact Name b. Telephone Number c. E-mail
​Mr.
​Christian Shalgian
​2023372701
​surgeonspac@facs.org
5. Senate ID#
​91251-12
7. Client Name Self Check if client is a state or local government or instrumentality
​American College of Surgeons Professional Association
6. House ID#
​363620000
TYPE OF REPORT 8. Year
​2020
 Q1 (1/1 - 3/31) Q2 (4/1 - 6/30) Q3 (7/1 - 9/30) Q4 (10/1 - 12/31)

9. Check if this filing amends a previously filed version of this report

10. Check if this is a Termination Report Termination Date
​
11. No Lobbying Issue Activity
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13
12. Lobbying 13. Organizations
INCOME relating to lobbying activities for this reporting period was: EXPENSE relating to lobbying activities for this reporting period were:
Less than $5,000
Less than $5,000
$5,000 or more $
​
$5,000 or more $
​10,400.00
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options.
Method A. Reporting amounts using LDA definitions only

Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code

Method C. Reporting amounts under section 162(e) of the Internal Revenue Code

Signature
Digitally Signed By: Christian Shalgian
 Date
1/19/2021 1:33:30 PM

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA)
PL 116-127/H.R. 6201 - Families First Coronavirus Response Act
H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act
H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act
H.R. 7059: Coronavirus Provider Protection Act
S. 1895 - Lower Health Care Costs Act
H.R. 5800 - Ban Surprise Billing Act
H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act
H.R. 3630 - No Surprises Act
H. R. 8 - Bipartisan Background Checks Act of 2019
H. R. 1418 - Competitive Health Insurance Reform Act of 2019
S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019
S. 966 - Medicare Care Coordination Improvement Act of 2019
S. 2372 - VA MISSION Act of 2018
S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019
H. R. 1379 - Ensuring Lasting Smiles Act
H. R. 207 - Stop the Violence Act of 2019
H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction)
H. R. 1041 - Critical Access Hospital Relief Act of 2019
H.R. 3656/S. 1350 - ACCESS Act of 2019
H.R. 861 - End Surprise Billing Act
H.R. 3630 - No Surprises Act
H.R. 3502 - Protecting People from Surprise Medical Bills Act
H.R. 2550 - Prevent BLEEDing Act of 2019
H. R. 2143 - Promoting Integrity in Medicare Act of 2019
H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019
H. R. 1332 - Fair Care Act of 2019
H.R. 2464 - End the Cycle of Violence Act of 2019
S. 1895 - Lower Health Care Costs Act
S. 967 - Reducing Costs for Out of Network Services Act
S. 1266 - Protecting Patients from Surprise Medical Bills Act
S. 1531 - Stopping the Outrageous Practice of Surprise Bills Act
S. 1607 - Medical Billing Fairness Act
H. R. - 1763/S. 348 - Resident's Physician Shortage Reduction Act
S. 1350 - Good Samaritan Health Professionals Act
H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization
H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019
H.R. 5855 - Bipartisan Solution to Cyclical Violence Act of 2020
H.R. 6953 - Pandemic Responder Service Award Act
H.R. 6644/S. 3741 - Telehealth legislation/The Health Care at Home Act
H.R. 6365/S. 3559 - Immediate Relief for Rural Facilities Act
H.R. 7255 - Coronavirus Health Care Worker Wellness Act
S. 3741 - Health Care at Home Act
S. 3750/H.R. 6837 - Medicare Accelerated and Advanced Payments Improvement Act
H.R.133 - Consolidated Appropriations Act, 2021
Phase 4 COVID-19 relief legislation
H. R. 8702 - Holding Providers Harmless from Medicare Cuts During COVID-19 Act
Federal Incentive Programs
COVID-Safely Returning to Work and School in the Fall
COVID-PPE Shortages
Mental Health Issues
Health Care Disparities
Cures 2.0
E/M Global Code Issues
Unique Patient Identifier
Lower Health Care Costs Act Compromise
Bleeding Control for the Injured (Stop The Bleed campaign)
Qualified clinical data registry (QCDR)
Firearms Safety and Research
MACRA Implementation
Merit-based Incentive Payment Systems (MIPS)
MIPS Value Pathways (MVPs)
Alternative Payment Models (APM)
Outpatient Prospective Payment System (OPPS)
Common Rule
Medicare for All
National Trauma Systems Legislation
Drug Pricing
Patient-Centered Outcomes Research Institute (PCORI)
Measuring Surgical Quality
Medicare Physician Reimbursement
Cancer Research and Funding
Trauma Research and Funding
Opioids/Pain Management Legislation
ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency)
Reauthorization of Patient-Centered Outcomes Research Institute (PCORI)
2020 CMS Proposed Fee Schedule
Rare earth magnet legislation

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Medicare Payment Advisory Commission (MedPAC), Health & Human Services - Dept of (HHS)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Christian
Shalgian
​
​
Patrick
Bailey
MDFACS
​
Matthew
Coffron
​
​
Carrie
Zlatos
​
​
Kristin
McDonald
​
​
Katie
Oehmen
​
​
Hannah
Chargin
​
​
Amelia
Suermann
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

PL 109-417 - Pandemic and All-Hazards Preparedness Act (PAHPA)
PL 116-127/H.R. 6201 - Families First Coronavirus Response Act
H.R. 6365/S. 3559 - The Immediate Relief for Rural Facilities and Providers Act
H.R. 748/S. 3548 - Coronavirus Aid, Relief, and Economic Security (CARES) Act
H.R. 7059: Coronavirus Provider Protection Act
S. 1895 - Lower Health Care Costs Act
H.R. 5800 - Ban Surprise Billing Act
H.R. 5826 - Consumer Protections Against Surprise Medical Bills Act
H.R. 3630 - No Surprises Act
H. R. 8 - Bipartisan Background Checks Act of 2019
H. R. 1418 - Competitive Health Insurance Reform Act of 2019
S. 668/H.R. 1570 - Removing Barriers to Colorectal Cancer Screening Act of 2019
S. 966 - Medicare Care Coordination Improvement Act of 2019
S. 2372 - VA MISSION Act of 2018
S. 741/H. R. 1730 - Cancer Drug Parity Act of 2019
H. R. 1379 - Ensuring Lasting Smiles Act
H. R. 207 - Stop the Violence Act of 2019
H. R. 1841 - Ensuring Access to General Surgery Act of 2019 (and Senate version reintroduction)
H. R. 1041 - Critical Access Hospital Relief Act of 2019
H.R. 3656/S. 1350 - ACCESS Act of 2019
H.R. 861 - End Surprise Billing Act
H.R. 3630 - No Surprises Act
H.R. 3502 - Protecting People from Surprise Medical Bills Act
H.R. 2550 - Prevent BLEEDing Act of 2019
H. R. 2143 - Promoting Integrity in Medicare Act of 2019
H. R. 3107 - Improving Seniors' Timely Access to Care Act of 2019
H. R. 1332 - Fair Care Act of 2019
H.R. 2464 - End the Cycle of Violence Act of 2019
S. 1895 - Lower Health Care Costs Act
S. 967 - Reducing Costs for Out of Network Services Act
S. 1266 - Protecting Patients from Surprise Medical Bills Act
S. 1531 - Stopping the Outrageous Practice of Surprise Bills Act
S. 1607 - Medical Billing Fairness Act
H. R. - 1763/S. 348 - Resident's Physician Shortage Reduction Act
S. 1350 - Good Samaritan Health Professionals Act
H. R. 2689/S. 1438 - Breast Cancer Research Stamp reauthorization
H.R. 4350/S. 3085 - Ambulatory Surgical Center Quality and Access Act of 2019
H.R. 5855 - Bipartisan Solution to Cyclical Violence Act of 2020
H.R. 6953 - Pandemic Responder Service Award Act
H.R. 6644/S. 3741 - Telehealth legislation/The Health Care at Home Act
H.R. 6365/S. 3559 - Immediate Relief for Rural Facilities Act
H.R. 7255 - Coronavirus Health Care Worker Wellness Act
S. 3741 - Health Care at Home Act
S. 3750/H.R. 6837 - Medicare Accelerated and Advanced Payments Improvement Act
H.R.133 - Consolidated Appropriations Act, 2021
Phase 4 COVID-19 relief legislation
H. R. 8702 - Holding Providers Harmless from Medicare Cuts During COVID-19 Act
Federal Incentive Programs
COVID-Safely Returning to Work and School in the Fall
COVID-PPE Shortages
Mental Health Issues
Health Care Disparities
Cures 2.0
E/M Global Code Issues
Unique Patient Identifier
Lower Health Care Costs Act Compromise
Bleeding Control for the Injured (Stop The Bleed campaign)
Qualified clinical data registry (QCDR)
Firearms Safety and Research
MACRA Implementation
Merit-based Incentive Payment Systems (MIPS)
MIPS Value Pathways (MVPs)
Alternative Payment Models (APM)
Outpatient Prospective Payment System (OPPS)
Common Rule
Medicare for All
National Trauma Systems Legislation
Drug Pricing
Patient-Centered Outcomes Research Institute (PCORI)
Measuring Surgical Quality
Medicare Physician Reimbursement
Cancer Research and Funding
Trauma Research and Funding
Opioids/Pain Management Legislation
ACS THRIVE (Transforming Health care Resources to Increase Value and Efficiency)
Reauthorization of Patient-Centered Outcomes Research Institute (PCORI)
2020 CMS Proposed Fee Schedule
Rare earth magnet legislation

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Medicare Payment Advisory Commission (MedPAC)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Christian
Shalgian
​
​
Patrick
Bailey
MDFACS
​
Matthew
Coffron
​
​
Carrie
Zlatos
​
​
Kristin
McDonald
​
​
Katie
Oehmen
​
​
Hannah
Chargin
​
​
Amelia
Suermann
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

Cancer Research and Funding
Opioid Legislation
Firearms CDC Research Funding

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Disease Control & Prevention (CDC)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Christian
Shalgian
​
​
Patrick
Bailey
MDFACS
​
Matthew
Coffron
​
​
Carrie
Zlatos
​
​
Kristin
McDonald
​
​
Katie
Oehmen
​
​
Hannah
Chargin
​
​
Amelia
Suermann
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code VET

16. Specific lobbying issues

S. 2372 - VA MISSION Act of 2018
H.R. 880/S. 1022 - Mission Zero Act
National Trauma System (Military-Civilian Trauma Care)


17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)

18. Name of each individual who acted as a lobbyist in this issue area

First Name Last Name Suffix Covered Official Position (if applicable) New
Christian
Shalgian
​
​
Patrick
Bailey
MDFACS
​
Matthew
Coffron
​
​
Carrie
Zlatos
​
​
Kristin
McDonald
​
​
Katie
Oehmen
​
​
Hannah
Chargin
​
​
Amelia
Suermann
​
​

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

Address
​
City
​
State
​
Zip Code
​
Country
​

21. Client new principal place of business (if different than line 20)

City
​
State
​
Zip Code
​
Country
​

22. New General description of client’s business or activities

​

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

First Name
Last Name
Suffix
First Name
Last Name
Suffix
1
​
​
​
3
​
​
​
2
​
​
​
4
​
​
​

ISSUE UPDATE

24. General lobbying issue that no longer pertains

​
​
​
​
​
​
​
​
​

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

Name Address Principal Place of Business
(city and state or country)
Street Address
City State/Province Zip Country
City
State Country

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

1 2 3

FOREIGN ENTITIES

27. Add the following foreign entities:

Name Address Principal place of business
(city and state or country) 		Amount of contribution for lobbying activities Ownership percentage in client
Street Address
City State/Province Country
City
State Country
%

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

1 3 5
2 4 6

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?

Lobbyist Name Description of Offense(s)